A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

New study reveals semaglutide outperforms liraglutide in ... Moreover, 20.3% of the study participants were Black, 7% were Hispanic, 68.5% were White, and 3.4% belonged to other races or ethnicities.